4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-25-010590
Chair and CEO sold 25,580 shares at an average $77.79 ($1,989,797)
- Chair and CEO acquired 25,580 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lewis William · Chair and CEO
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +18,750 | $22.76 | $426,750 | 352,936 | D |
| 2025-03-03 | Sale : show line 2 in the form 10b5-1 | −7,317 | $76.24 | $557,848 | 345,619 | D |
| 2025-03-03 | Sale : show line 3 in the form 10b5-1 | −758 | $77.75 | $58,935 | 344,861 | D |
| 2025-03-03 | Sale : show line 4 in the form 10b5-1 | −7,763 | $78.61 | $610,249 | 337,098 | D |
| 2025-03-03 | Sale : show line 5 in the form 10b5-1 | −2,785 | $79.43 | $221,213 | 334,313 | D |
| 2025-03-03 | Sale : show line 6 in the form 10b5-1 | −127 | $80.90 | $10,274 | 334,186 | D |
| 2025-03-03 | Exercise or conversion : show line 7 in the form 10b5-1 | +6,830 | $10.85 | $74,106 | 240,754 | I |
| 2025-03-03 | Sale : show line 8 in the form 10b5-1 | −2,671 | $76.23 | $203,610 | 238,083 | I |
| Open-market sales · 25,580 sh · avg $77.79 · $1,989,797 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-03 | Exercise or conversion : show line 13 in the form 10b5-1 Stock Option (right to buy) | −18,750 | 18,750 | D |
| 2025-03-03 | Exercise or conversion : show line 14 in the form 10b5-1 Stock Option (right to buy) | −6,830 | 198,140 | I |
Loading xslF345X05/wk-form4_1741213663.xml…